A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma
Condition(s):Malignant Pleural Mesothelioma, Advanced; Malignant Pleural Mesothelioma, UnresectableLast Updated:May 13, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Malignant Pleural Mesothelioma, Advanced; Malignant Pleural Mesothelioma, UnresectableLast Updated:May 13, 2021Withdrawn
Condition(s):Mesotheliomas PleuralLast Updated:April 19, 2023Recruiting
Condition(s):Mesotheliomas PleuralLast Updated:May 3, 2022Unknown status
Condition(s):Unresectable Pleural MesotheliomaLast Updated:March 26, 2024Recruiting
Condition(s):Malignant Pleural MesotheliomaLast Updated:August 6, 2015Unknown status
Condition(s):Malignant Pleural MesotheliomaLast Updated:June 2, 2023Recruiting
Condition(s):Malignant Pleural MesotheliomaLast Updated:January 30, 2017Terminated
Condition(s):Pleural MesotheliomaLast Updated:April 28, 2023Recruiting
Condition(s):Malignant Pleural Mesothelioma, AdvancedLast Updated:September 11, 2023Recruiting
Condition(s):Malignant Pleural MesotheliomaLast Updated:November 20, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.